1. A new device for exercise MR imaging;Schaefer, S.; Peshock, R.M.; Parkey, R.W.; Willerson, J.T.;Am J Roentgenol; niques we have also shown that the size of the thallium-201 defect is important. All patients without wall motion abnormalities induced by dipyridamole had thallium-201 defects affect- 147,1986
2. Evaluation of coronary artery disease in the patient unable to exercise: alternatives to exercise stress testing;Stratman, H.G.; Kennedy, H.L.;Am Heart J,1989
3. Dipyridamole echocardiography test: historical background and physiologic basis;Picano, E.;Eur Heart J; 10: ing two or fewer segments, while only two patients with wall motion abnormalities had reversible thallium-20 1 defects affecting less than two segments. There was a similar relation with the number of diseased,1989
4. Dipyridamole radionuclide ventriculographv: a test with high specificity for severe coronary artery disease;Cates, C.U.; Kronenberg, M.W.; Collins, H.W.; Sandler, M.P.;J Am, Coll Cardiol,1989
5. Myocardial imaging with dipyridamole: comparison of the sensitivity and specificity of Thallium-201 versus MUGA;Harris, D.; Taylor, D.; Condon, B.; Ackery, D.; Conway, N.;J Nucl Med,1982